SCHEMBL3393739

SCHEMBL3393739

Cn1nccc1-c1ccc(-c2cnc3[nH]cc(CC(C)(C)C=O)c3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 15/20 0.39
PDPK1 O15530 1/20 0.38
JAK3 P52333 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MTOR P42345 1/20 0.34
CD274 Q9NZQ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399285 0.92 PDPK1 (0.38) MAPK1PDPK1JAK3CYP2D6
SCHEMBL3398594 0.83 MAPK1 (0.38) MAPK1JAK3CYP2D6
SCHEMBL3396888 0.81 MAPK1 (0.37) MAPK1JAK3CYP2D6MTOR
SCHEMBL3396186 0.78 MAPK1 (0.44) MAPK1
SCHEMBL3396338 0.78 BRD4 (0.44) MAPK1JAK3
SCHEMBL3397717 0.78 MAPK1 (0.41) MAPK1JAK3CYP19A1
SCHEMBL2279263 0.77 JAK3 (0.55) MAPK1JAK3
SCHEMBL3397744 0.76 NPC1 (0.41) MAPK1JAK3CYP2D6
SCHEMBL3395584 0.76 MAP4K1 (0.45) MAPK1
SCHEMBL3398248 0.76 MAPK1 (0.40) MAPK1JAK3CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP claimed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO claimed
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO disclosed